{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:23:01Z","timestamp":1790943781023,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.braindev.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T02:31:19Z","timestamp":1311733879000},"page":"298-301","source":"Crossref","is-referenced-by-count":3,"title":["Cerebrospinal fluid apolipoprotein e levels in subacute sclerosing panencephalitis"],"prefix":"10.1016","volume":"34","author":[{"given":"Deniz","family":"Y\u00fcksel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ichiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2011.07.001_b0005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.braindev.2011.07.001_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2011.07.001_b0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/1098-1136(20010315)33:4<298::AID-GLIA1028>3.0.CO;2-N","article-title":"Synthesis and processing of apolipoprotein E in human brain cultures","volume":"33","author":"Dekroon","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.braindev.2011.07.001_b0020","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.pnpbp.2006.04.007","article-title":"Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer\u2019s disease, frontotemporal dementia and schizophrenia with therapeutic implications","volume":"30","author":"Deutsch","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.braindev.2011.07.001_b0025","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.braindev.2011.07.001_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.braindev.2011.07.001_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2008.05.076","article-title":"CSF beta-amyloid 1\u201342 and tau in Tunisian patients with Alzheimer\u2019s disease: the effect of APOE epsilon4 allele","volume":"440","author":"Smach","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.braindev.2011.07.001_b0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(96)12774-9","article-title":"Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer\u2019s disease","volume":"212","author":"Lefranc","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.braindev.2011.07.001_b0045","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/088307380101601206","article-title":"Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE)","volume":"16","author":"Anlar","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2011.07.001_b0050","first-page":"133","article-title":"Neurofibrillary pathology in subacute sclerosing panencephalitis","volume":"2","author":"Wisniewski","year":"1991","journal-title":"Dementia"},{"key":"10.1016\/j.braindev.2011.07.001_b0055","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.42.3.488","article-title":"Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis","volume":"42","author":"Yalaz","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2011.07.001_b0060","first-page":"493","article-title":"SSPE: clinical staging, course, and frequency","volume":"32","author":"Jabbour","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2011.07.001_b0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.braindev.2011.07.001_b0070","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J Lipid Res"},{"key":"10.1016\/j.braindev.2011.07.001_b0075","first-page":"363","article-title":"Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases","volume":"132","author":"Anoop","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.braindev.2011.07.001_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1155\/2006\/951632","article-title":"In temporal lobe epilepsy: a case-control study","volume":"22","author":"Kumar","year":"2006","journal-title":"Dis Markers"},{"key":"10.1016\/j.braindev.2011.07.001_b0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-511X-9-8","article-title":"Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review","volume":"9","author":"Kuhlmann","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.braindev.2011.07.001_b0090","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/JVI.00006-06","article-title":"Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA","volume":"80","author":"Burgos","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.braindev.2011.07.001_b0095","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/2677","article-title":"HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy","volume":"4","author":"Corder","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.braindev.2011.07.001_b0100","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","article-title":"Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro","volume":"264","author":"Nathan","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.braindev.2011.07.001_b0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1469-8749.2005.tb01042.x","article-title":"Apolipoprotein E and brain injury: implications for children","volume":"47","author":"Blackman","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2011.07.001_b0110","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","article-title":"Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice","volume":"100","author":"Harris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.braindev.2011.07.001_b0115","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform\u2013specific interactions of apolipoprotein E with microtubule\u2013associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.braindev.2011.07.001_b0120","doi-asserted-by":"crossref","first-page":"29605","DOI":"10.1074\/jbc.M109.039560","article-title":"Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin","volume":"284","author":"Hayashi","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2011.07.001_b0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-4886(03)00088-8","article-title":"APOE epsilon 3\/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer\u2019s disease diagnosis","volume":"183","author":"Fukumoto","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.braindev.2011.07.001_b0130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jnr.21874","article-title":"COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia","volume":"87","author":"Tukhovskaya","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.braindev.2011.07.001_b0135","doi-asserted-by":"crossref","first-page":"e8191","DOI":"10.1371\/journal.pone.0008191","article-title":"Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic drosophila model of Alzheimer\u2019s disease","volume":"4","author":"Sarantseva","year":"2009","journal-title":"PLoS One"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776041100177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776041100177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:25:51Z","timestamp":1638145551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S038776041100177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S038776041100177X"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2011.07.001","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}